Casey Kerrigan, MD, MS, Department Chair, Professor of Physical Medicine and Rehabilitation, University of Virginia Health System, discusses osteoarthritis in the tibiofemoral joint and knee varus torque, which…
Rory J Todhunter, BVSc, PhD, Diplomate – American College of Veterinary Internal Medicine, Professor of Surgery, Cornell University College of Veterinary Medicine, describes how restricting canine growth rate…
NEW YORK (Reuters Health) – Seven years from now it is very unlikely there will be enough surgeons in the US to perform the estimated 427,500 total hip…
NEW YORK (Reuters Health) – Treatment with the anti-tumor necrosis factor antibody adalimumab may arrest bone loss in patients with rheumatoid arthritis, according to study results reported in…
NEW YORK (Reuters Health) – A 6-week program of progressive volitional strength training targeting the quadriceps femoris muscle group substantially improves strength and function following total knee arthroplasty…
NEW YORK (Reuters Health) – In patients with rheumatoid arthritis, anti-tumor necrosis factor (TNF) treatment with adalimumab and infliximab is associated with a small increased risk of herpes…
NEW YORK (Reuters Health) – In patients with diffuse cutaneous systemic sclerosis (dcSSc), treatment with rituximab depletes B cells in the peripheral circulation and in skin, with few…
NEW YORK (Reuters Health) – In middle-aged Chinese adults, hyperuricemia is an independent risk factor for all-cause mortality, cardiovascular disease, and ischemic stroke, according to results of prospective…
NEW YORK (Reuters Health) – The prognosis for patients with systemic sclerosis complicated by pulmonary hypertension is “grim,” particularly among African Americans and those with interstitial lung disease,…